pubmed· e01.org

PubMed · PMID 23463189

Neurotrophic molecules in the treatment of neurodegenerative disease with focus on the retina: status and perspectives.

PMID 23463189Journal Cell and tissue researchYear 2013Authors 1DOI 10.1007/s00441-013-1585-y

  • Source PubMed
  • Journal Cell and tissue research
  • Year 2013
  • Authors Klaus Unsicker
  • Licence NLM/PubMed terms

Abstract

Neurotrophic factors are operationally defined as molecules that promote the survival and differentiation of neurons. Chemically, they belong to divergent classes of molecules but most of the classic neurotrophic factors are proteins. Together with stem cells, viral vectors and genetically engineered cells, they constitute important tools in neuroprotective and regenerative neurobiology. Protein neurotrophic molecules signal through receptors located on the cell membrane.

Their downstream signaling exploits pathways that are often common to chemically different factors and frequently target a relatively restricted set of transcription factors, RNA interference and diverse molecular machinery involved in the life vs. death decisions of neurons.

Application of neurotrophic factors with the aim of curing or, at least, improving the outcome of neurodegenerative diseases requires (1) profound knowledge of the complex molecular pathology of the disease, (2) the development of animal models as closely as possible resembling the human disease, (3) the identification of target cells to be addressed, (4) intense efforts in chemical engineering to ensure the stability of molecules or to design carriers and small analogs with the ability to cross the blood-brain barrier and (5) scrutinity with regard to possible side effects.

Last, but not least, engineering efforts to optimize administration, e.g., by designing the right canulae and infusion devices, are important for the successful translation of preclinical advances into clinical benefit. This article presents selected examples of neurotrophic factors that are currently being tested in animal models or developed for transfer to the clinic, with a major focus on factors with the potential of becoming applicable in various forms of retinal degeneration.

Record details

PMID23463189
DOI10.1007/s00441-013-1585-y
JournalCell and tissue research
Year2013
AuthorsKlaus Unsicker
MeSHAnimals; Cytokines; Humans; Nerve Growth Factors; Neurodegenerative Diseases; Neuroprotective Agents; Retina; Retinal Ganglion Cells

Source record

Open the PubMed record. This page reproduces the abstract and citation fields held in the local baseline; it does not rehost the article.

Source
PubMed / NLM
PMID
23463189
Rendered
2026-11-20
Completeness
Abstract and citation fields only; full text is not rehosted.